OMC Earnings

OMC reported its FY2025Q4 earnings on 2026-02-10, showcasing a revenue of 0.00 against an estimate of 5.00B, resulting in a 0% surprise. The EPS was 0, surpassing the expected 2.59 by 0% . The stock experienced a 0% price change on the earnings day and a 0% change over the next five days, reflecting market reactions to the results.

Following OMC's FY2025Q4 earnings announcement on 2026-02-10, the stock price moved by % on the day of the release. Over the subsequent five days, it saw a % change. Historically, OMC's stock price tends to shift by an average of -0.32% in the 10 days leading up to earnings and -0.69% in the 10 days following, providing insight into potential market.

For 2025/Q4, analysts estimate OMC’s annual revenue to reach 6.00B, while the EPS is projected at 3.00. These estimates reflect recent revisions, with revenue estimates revised Revenue No Change by 0% and EPS estimates Revise Upward by 36.55% over the past three months, indicating analyst expectation in the company’s performance.

The correlation between OMC's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock’s fundamentals. Over the past three months, revenue estimates for FY2025 were No Change by 0%, while EPS estimates moved Revise Upward by 36.55% . This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, OMC's stock price typically moves by -0.32% in the 10 days before its earnings and -0.69% in the 10 days after. For the upcoming 2025/Q4 earnings, analysts expect an EPS of 3.00 and revenue of 6.00B.

The earnings call reveals strong financial performance with a 26% adjusted rate, solid ROIC and ROE, and significant share repurchases. Despite some deceleration in European Precision Marketing, management remains confident in organic growth and merger synergies. Positive client reception and robust media growth, supported by AI integration, suggest optimism. The Q&A indicates management's proactive approach to challenges and opportunities, especially in media and healthcare. Overall, the elements point to a positive stock price movement, likely in the 2% to 8% range over the next two weeks.